Podcast

Pharmacy Focus Podcast: Move the Needle Monday- Episode 5

Amid the COVID-19 pandemic, health care providers are focusing on the health of younger individuals.

In this month's episode, Dr. Maria Lopez joins Ed Cohen and John Beckner to discuss continued immunization activity at the pharmacy with a focus on younger patients.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: komokvm | stock.adobe.com
Children's doctor vaccinating little boy at home.
Covid-19 Vaccine New Variant 2024-2025 | Image Credit: New Africa - stock.adobe.com
COVID-19 vaccine 2024-2025 Season | Image Credit: Alernon77 - stock.adobe.com
Vaccinating an elderly person.
Doctor hands making a vaccination in the shoulder of patient
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD
Related Content
Streptococcus Pneumoniae Bacteria
June 30th 2025

21-Valent Pneumococcal Conjugate Vaccine Exhibits Consistent Safety and Immunogenicity Across Manufacturing Lots

Luke Halpern, Assistant Editor
An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial
July 1st 2025

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Atlanta, GA, USA - June 15, 2022: The Closeup of the CDC logo seen at the Edward R. Roybal campus, the headquarters of the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.
June 26th 2025

ACIP Recommends Adults Receive Seasonal, Single-Dose Influenza Vaccines Free of Thimerosal

Luke Halpern, Assistant Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
PNEUMOVAX box, pneumococcal vaccine for treatment of infections caused by bacteria called pneumococcus
June 24th 2025

23-Valent Pneumococcal Polysaccharide Vaccine Provides Protection Up To 6 Years Following Vaccination

Luke Halpern, Assistant Editor
Cropped of black man receiving vaccine shot
June 20th 2025

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Luke Halpern, Assistant Editor